Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > The effect of ETI (Trikafta™) on blood sugars in adults with cystic fibrosis

The effect of ETI (Trikafta™) on blood sugars in adults with cystic fibrosis

Resource Type

CF Research News

Authors

Kevin J Scully, Peter Marchetti, Gregory S Sawicki, Ahmet Uluer, Manuela Cernadas, Rebecca E Cagnina, John C Kennedy, Melissa S Putman

References

J Cyst Fibros. 2021 Sep 13;S1569-1993(21)01377-1. doi: 10.1016/j.jcf.2021.09.001.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR modulator [3]
continuous glucose monitoring [4]
Cystic fibrosis related diabetes [5]
Elexacaftor-tezacaftor-ivacaftor [6]

Date

Monday, September 13, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/effect-eti-trikafta%E2%84%A2-blood-sugars-adults-cystic-fibrosis

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00264R1_FINAL_Putman_200921.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34531155/ [3] https://www.ecfs.eu/research-article-keywords/cftr-modulator [4] https://www.ecfs.eu/research-article-keywords/continuous-glucose-monitoring [5] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis-related-diabetes [6] https://www.ecfs.eu/research-article-keywords/elexacaftor-tezacaftor-ivacaftor [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines